Hepatitis Diagnostic Test Market

Hepatitis Diagnostic Test Market by Tests (Blood Tests [Immunoassays, Nucleic Acid Tests, and Liver Function Tests], Imaging Tests, and Liver Biopsy) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.

  • Report ID: HC-1437
  • Author: Growth Market Reports
  • Rating: 4.7
  • Total Reviews: 165
  • No. Of Pages: 150
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global hepatitis diagnostic test market size was valued at USD 4.95 billion in 2020 and is anticipated to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising cases of hepatitis along with increase in awareness of the disease and rising need to identify the type of virus.

Hepatitis Diagnostic Test Market Key Takeaways

Hepatitis is characterized as inflammation of the liver. It is categorized on the basis of different type of viruses as Hepatitis A, B, and C. The disease is diagnosed by the type of virus present in the blood of the patient or the other method is by identifying the antibodies developed in the body against the virus. The genetic testing of hepatitis includes molecular diagnostics to confirm the exact strain of the virus. One key aspect of the market expansion is due to the rapid development of modern diagnostic technologies such as nucleic acid assays, which include HBV DNA and HCV RNA analysis tests. The development leads to provide effective and accurate diagnostic results with shorter duration.

This disorder, without having access to early detection and a proper treatment, is likely to lead various severe health conditions including liver cirrhosis, liver cancer, and fibrosis or scarring in liver. The infection of hepatitis can occur due to factors such as viral infection, toxins, alcohol, side effects of medications or drugs, and autoimmune hepatitis. According to World Health Organization (WHO), liver cancer is caused mainly due to hepatitis and the disorder is responsible for nearly 80% of all cases related to liver cancer reported globally with nearly 1.5 million deaths annually. The report also states that about 310 chronic cases are recorded worldwide. As per the U.S. Department of Health & Human Services, around 37% of newly recorded chronic hepatitis C cases are occurred to the people between the age of 20 to 30 years in 2018 and this is anticipated to surge during the forecast period.

Market Trends, Drivers, Restraints, and Opportunities

  • High prevalence of hepatitis globally, rising number of blood transfusions and donations, and awareness initiatives about the disease are expected to boost the market expansion during the forecast period.
  • Rising growth of medical tourism, growing disposable income of consumers, and the rising great demography of undiagnosed people are the key factors driving the market.
  • Increasing research and development activities, technological developments in the healthcare sector, and emerging markets are creating new opportunities for the market development.
  • Deficiency of any compulsory directive issued by the authorities in developing countries as well as high cost of Nucleic Acid Amplification Testing (NAT) for the testing of hepatitis virus are proving to be major restraints to the market growth.

Scope of the Report

The report on the global hepatitis diagnostic test market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Hepatitis Diagnostic Test Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Tests (Blood Tests [Immunoassays, Nucleic Acid Tests, and Liver Function Tests], Imaging Tests, and Liver Biopsy)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Abbott Laboratories; F. Hoffmann La-Roche; bioMeriuex; MedMira; Inc.; DiaSorin S.p.A; Hologic; Inc.; Siemens Healthineers; Danaher Corporation; and Bio-Rad Laboratories.

Market Segment Insights

Blood test segment is anticipated to expand at a robust pace

Based on tests, the global hepatitis diagnostic test market is segregated into blood tests, imaging tests, and liver biopsy. The blood test segment is further classified into immunoassays, nucleic acid tests, and liver function tests. The blood test segment is anticipated to expand at a robust pace in the coming years as it is considered to the wide available and most adopted diagnosis test for detecting hepatitis and its treatment. In the blood test, the liver function test is most widely used for liver diseases, which is why the segment has showed promising results to flourish during the projected period. To detect the presence of a specific virus in the sample, immunoassays test are primarily adopted as the test utilizes antibodies and antigens to perform the detection. Techniques such as PCR system, ELISA, RIBA, and CLIA are used to perform immunoassays that are expensive for most of the patients around the world.

Meanwhile, the imaging test is projected to exhibit a high CAGR during the forecast period owing to its wide adoption for the screening process. The test is basically performed to confirm the results of blood test; thereby, showing lucrative potentials for the segment growth. On the other hand, the liver biopsies segment is expected to hold a considerable market share as it is performed to detect the viral strain in case of chronic conditions. Biopsies are used to identify cancer cells in liver after hepatitis infection.

Hepatitis Diagnostic Test Market By Tests

North America is anticipated to constitute a major market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a major share of the market in the coming years owing to the availability of advanced diagnostic tools and high awareness regarding the healthcare products. Moreover, wide establishment of proper infrastructure for healthcare services and the availability of skilled professional in the region present key factors driving the regional market growth. The growth of the market in the region is further attributed by the development of several government and non-government organizations’ awareness initiative. For example, The Public Health Agency of Canada arranged the World Hepatitis Day to increase awareness concerning hepatitis diagnostics.

Meanwhile, the market of Asia Pacific is anticipated to expand at a significant CAGR during the forecast period owing to wide incidence of hepatitis cases and growing per capita income of a large number of consumers in the region. Increasing concerns from government agencies to develop advanced healthcare facilities and equipment has created a huge opportunity to proliferate the market growth in the region. According to the WHO reports, the prevalence of hepatitis Type B in South East Asia is approximately 0.7% as well as the incidence rate of HCV infection is 1.48 in 1,000,000 people.

Hepatitis Diagnostic Test Market By Regions

Segments

Segments Covered in the Report
The global hepatitis diagnostic test market has been segmented on the basis of

Tests
  • Blood Tests
    • Immunoassays
    • Nucleic Acid Test
    • Liver Function Test
  • Imaging Tests
  • Liver Biopsy
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Abbott Laboratories
  • F. Hoffmann La-Roche
  • bioMeriuex
  • MedMira; Inc.
  • DiaSorin S.p.A
  • Hologic; Inc.
  • Siemens Healthineers
  • Danaher Corp.
  • Bio-Rad Laboratories.

Competitive Landscape

Key players competing in the global hepatitis diagnostic test market include Abbott Laboratories; F. Hoffmann La-Roche; bioMeriuex; MedMira; Inc.; DiaSorin S.p.A; Hologic; Inc.; Siemens Healthineers; Danaher Corporation; and Bio-Rad Laboratories. Some of these key players are consistently engaged in to adopt several market strategies including product launches, acquisitions, collaborations, and capacity expansion to enhance their market position.

Hepatitis Diagnostic Test Market By Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hepatitis Diagnostic Test Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Hepatitis Diagnostic Test Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Hepatitis Diagnostic Test Market - Supply Chain
  4.5. Global Hepatitis Diagnostic Test Market Forecast
     4.5.1. Hepatitis Diagnostic Test Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Hepatitis Diagnostic Test Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Hepatitis Diagnostic Test Market Absolute $ Opportunity
5. Global Hepatitis Diagnostic Test Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Hepatitis Diagnostic Test Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Hepatitis Diagnostic Test Demand Share Forecast, 2019-2026
6. North America Hepatitis Diagnostic Test Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Hepatitis Diagnostic Test Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Hepatitis Diagnostic Test Demand Share Forecast, 2019-2026
7. Latin America Hepatitis Diagnostic Test Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Hepatitis Diagnostic Test Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Hepatitis Diagnostic Test Demand Share Forecast, 2019-2026
8. Europe Hepatitis Diagnostic Test Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Hepatitis Diagnostic Test Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Hepatitis Diagnostic Test Demand Share Forecast, 2019-2026
9. Asia Pacific Hepatitis Diagnostic Test Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Hepatitis Diagnostic Test Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Hepatitis Diagnostic Test Demand Share Forecast, 2019-2026
10. Middle East & Africa Hepatitis Diagnostic Test Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Hepatitis Diagnostic Test Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Hepatitis Diagnostic Test Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Hepatitis Diagnostic Test Market: Market Share Analysis
  11.2. Hepatitis Diagnostic Test Distributors and Customers
  11.3. Hepatitis Diagnostic Test Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Abbott Laboratories F. Hoffmann La-Roche bioMeriuex MedMira; Inc. DiaSorin S.p.A Hologic; Inc.  
Segments Covered in the Report
The global hepatitis diagnostic test market has been segmented on the basis of

Tests
  • Blood Tests
    • Immunoassays
    • Nucleic Acid Test
    • Liver Function Test
  • Imaging Tests
  • Liver Biopsy
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Abbott Laboratories
  • F. Hoffmann La-Roche
  • bioMeriuex
  • MedMira; Inc.
  • DiaSorin S.p.A
  • Hologic; Inc.
  • Siemens Healthineers
  • Danaher Corp.
  • Bio-Rad Laboratories.

Key players competing in the global hepatitis diagnostic test market include Abbott Laboratories; F. Hoffmann La-Roche; bioMeriuex; MedMira; Inc.; DiaSorin S.p.A; Hologic; Inc.; Siemens Healthineers; Danaher Corporation; and Bio-Rad Laboratories. Some of these key players are consistently engaged in to adopt several market strategies including product launches, acquisitions, collaborations, and capacity expansion to enhance their market position.

Hepatitis Diagnostic Test Market By Key Players

Buy Report